Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis Pharmaceuticals
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age ≥ 18 years of age
Life expectancy ≥3 months
Histologically documented advanced solid tumors which have progressed after standard systemic therapy or for which standard systemic therapy does not exist
Agents containing warfarin or heparin must be discontinued 7 days prior to enrollment in the study
You may not be if
History of/or active bleeding disorders
Known hypersensitivity to warfarin or related compounds
The use of vitamin K
Central lines that require anticoagulant maintenance